---
title: "TSH of 4.5 to 10: subclinical hypothyroidism, and what happens next"
url: https://nutritailor.co.uk/apps/learn/tsh-4-5-to-10-subclinical-hypothyroidism-what-happens-next
slug: tsh-4-5-to-10-subclinical-hypothyroidism-what-happens-next
pillar: Iron
publisher: "Nutri Tailor Health Reference Library"
editor: "Henry Bond"
publisher_makes: "Nutri365, the only UK app that combines your Oura data, blood test results and what you tell it into personalised guidance"
---

# TSH of 4.5 to 10: subclinical hypothyroidism, and what happens next

## Summary

A TSH above the reference range but below 10 mU/L with normal free T4 is subclinical hypothyroidism. NICE's sequence is a repeat at three months with free T4, because a large share of first results settle, thyroid peroxidase antibodies once, since positive antibodies make progression more likely, and then the decision. Under 65 with symptoms and two raised results, a six-month levothyroxine trial can be considered, stopped if symptoms persist once TSH is in range. Over 65, or without symptoms, monitoring applies, annually with antibodies or features and every two to three years without. Before the repeat, ferritin under 30 and marginal iodine are corrected. Anyone pregnant or planning sees a GP this week.

## How it works

The pituitary raises TSH when it senses the smallest fall in T4, so a gland that has lost some capacity, usually through autoimmune thyroiditis, shows a raised TSH long before T4 drops out of range. That is why free T4 is normal here and why antibodies matter: positive thyroid peroxidase antibodies identify the autoimmune process and predict which subclinical results will progress. A share of raised results are not disease at all: recovery from illness, iron deficiency limiting thyroid peroxidase, iodine shortfall, an afternoon draw, or simply lab variation, and those settle on repeat. Acting on the number when the cause is iron or a passing illness exposes people to a lifelong prescription for no benefit.

## Timing

Repeat at three months, not sooner, because TSH takes six weeks to settle after any change. Antibodies once. A levothyroxine trial runs six months before judgement. Unmanaged results are re-checked annually or every two to three years depending on features. Iron correction over the three months can move the repeat.

## Safety profile

Pregnancy or planning a pregnancy with a raised TSH is a GP matter within days, because antenatal thresholds are lower and timing matters. A TSH that has risen above 10, a falling free T4, a neck swelling, or marked symptoms bring the decision forward. Levothyroxine over-replacement suppresses TSH with atrial fibrillation and bone loss risk, which is why NICE is cautious over 65. Desiccated thyroid and online thyroid hormone are not options. Iodine excess can worsen autoimmune thyroiditis.

## Special populations

For over-65s, NICE leans to monitoring, and the reference range rises with age. Women planning pregnancy face earlier and lower thresholds. People with positive antibodies and a family history are more likely to progress, so annual checks apply. People with type 1 diabetes, coeliac disease or another autoimmune condition carry higher thyroid risk and are monitored more closely.

## Guideline positions

NICE NG145: consider measuring thyroid peroxidase antibodies once for adults with TSH above the reference range, not repeating; when discussing levothyroxine take into account symptoms, previous radioactive iodine therapy or thyroid surgery, and antibody status; consider a six-month trial of levothyroxine for adults under 65 with a TSH above the reference range but below 10 on two separate occasions three months apart and symptoms of hypothyroidism; stop the trial if symptoms persist with TSH in range, as they are then likely due to other causes; where levothyroxine is not started, consider TSH and free T4 annually if there are features of thyroid disease, or every two to three years if not. The committee's rationale notes that below 10 levothyroxine is less likely to benefit, the balance is most favourable under 65, and over 65 the harms of suppressing TSH, such as atrial fibrillation, are greater.

## Practical framework

Between the first result and the repeat, ferritin is checked and corrected if under 30, per the [ferritin hub](/apps/learn/ferritin-blood-test-results-explained-uk-what-your-number-means), because iron deficiency raises TSH and is the one cause removable at home. Iodine intake is reviewed on the [iodine page](/apps/learn/do-i-need-an-iodine-supplement-and-how-much-is-safe) and corrected by food or a modest supplement within the NHS ceiling, with no high-dose iodine and no kelp. The repeat is booked in the morning, not within a month of an illness, with free T4 and antibodies requested. The GP conversation then runs with the guideline in hand, covering symptoms, antibody result, age and the two TSH values. Where a six-month trial starts, levothyroxine is taken on an empty stomach, away from iron, calcium and coffee by four hours, and judged at six months on symptoms rather than only the number. Nutri365 reads whether fatigue, cold intolerance or weight track the TSH, the ferritin or the sleep across those months, checks for interactions and contraindications, and refers questions outside scope to a health specialist, with the thyroid decision itself staying with the GP.

## Common misconceptions

A raised TSH is not a diagnosis until it is repeated. Levothyroxine does not reliably improve symptoms below 10 and NICE stops the trial if it does not. Selenium and iodine supplements do not reverse autoimmune thyroiditis. A first raised result during or after a viral illness is often not thyroid disease.

## Sources

1.  (2023). Thyroid disease: assessment and management (NG145). NICE. https://www.nice.org.uk/guidance/ng145/chapter/recommendations.
2. Garofalo V, Condorelli RA, Cannarella R, Aversa A, Calogero AE, La Vignera S (2023). Relationship between Iron Deficiency and Thyroid Function: A Systematic Review and Meta-Analysis. Nutrients. PMID: 38004184.
3. Hess SY, Zimmermann MB, Arnold M, Langhans W, Hurrell RF (2002). Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition. PMID: 12097675.
4.  (2024). Iodine. NHS. https://www.nhs.uk/conditions/vitamins-and-minerals/iodine/.


---

Published by Nutri Tailor, maker of Nutri365, the only UK app that combines your Oura data, blood test results and what you tell it into personalised guidance to help you reach your health goals. Details: https://nutritailor.co.uk/apps/learn/nutri365
